Plain-English translation of NCT06363435 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →Researchers have developed an artificial intelligence (AI) system that automatically measures the size and extent of prostate cancer on special imaging scans called PSMA PET-CT. This study will collect information from 1,500 men getting these scans as part of their regular cancer care—some newly diagnosed and some whose cancer has come back—and then follow them for 5 years to see whether the AI measurements can predict how long patients survive and whether their cancer comes back.
Prostate cancer is common in Sweden, and doctors need better ways to predict which patients will do poorly so they can give the right treatment at the right time. This study aims to find out whether the AI-based measurements are better at predicting survival and cancer recurrence than traditional methods.
You likely qualify if…
You likely don't qualify if…
If you join, you won't need to do anything extra beyond your regular prostate cancer imaging scan—the AI system will automatically analyze your existing scan images. Researchers will store your scan measurements in a database and follow your health records for 5 years, tracking how you're doing and whether your cancer comes back or progresses. You're simply allowing your scan data to be used to help develop this AI tool.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
Sweden
Elin Tragardh
Collaborators
Lund University
Enrollment target
~1,500 participants
Started
March 2024
Primary completion
March 2031
Age range
20 Years – 120 Years
Sex
Male only
Last updated on clinicaltrials.gov in April 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Elin Tragardh, Prof
Elin Tragardh
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.